Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil

Table 1 Expression of cycle-related and expression-elevated protein in tumor in colorectal benign tumor and malignant tumor

	CREPT expression
	Low	Intermediate	High		P-value
Benign tumor	1	6	6		0.035a
Malignant tumor	25	21	157

^aP < 0.05, CREPT: Cycle-related and expression-elevated protein in tumor.

Table 2 Expression of cycle-related and expression-elevated protein in tumor in colorectal cancer according to clinicopathological parameters

	CREPT expression			P value
	Low	Intermediate	High
Tumor
T1	2	0	4	0.770
T2	3	2	25
T3	6	2	20
T4	14	17	108
Stage
I	4	2	23	0.700
II	11	12	64
III	8	3	56
IV	2	4	14
Histological grade
Poor	9	6	31	0.004b
Moderate	12	13	71
Well	4	2	55
Lymph node metastasis
Negative	15	15	92	0.487
Positive	10	6	65

^bP < 0.05, CREPT: Cycle-related and expression-elevated protein in tumor. CRC: Colorectal cancer.